Mira Pharmaceuticals Inc. (MIRA)
NASDAQ
0.7753
-0.01 (-1.61%)
Closed
Aug 25, 2026
Day's Range
0.76830.8100
52 wk Range
0.60002.45
Financial Statements - MIRA - Mira Pharmaceuticals Inc.
Revenue
0
Net Income
-10.44M▼ 33.0%
EBITDA
-10.45M▼ 30.4%
Free Cash Flow
-4.66M▲ 16.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Sales | 0 | 0 | - | 0 | 0 |
| Cost of Goods | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
 Operating Expense | - | - | - | - | - |
| Operating Income | -10.49M | -8.01M | - | -7.04M | -2.15M |
| Non-Operating Interest | - | - | - | - | - |
| Other Income Expense | -48.28K | - | - | - | - |
| Pre Tax Income | -10.44M | -7.85M | - | -7.05M | -2.17M |
| Income Tax | - | - | - | - | - |
| Net Income | -10.44M | -7.85M | - | -7.05M | -2.17M |
| EPS Basic | -1.35 | -0.51 | -0.64 | -0.39763 | -0.14761 |
| EPS Diluted | -1.35 | -0.51 | -0.64 | -0.39763 | -0.14761 |
| Basic Shares Outstanding | 23.69M | 15.44M | 18.56M | 17.75M | 14.74M |
| Diluted Shares Outstanding | 23.69M | 15.44M | 18.56M | 17.75M | 14.74M |
| Ebit | -10.49M | -8.01M | - | -7.04M | -2.15M |
| Ebitda | -10.45M | -8.01M | - | -7.04M | -2.15M |
| Net Income Continuous Operations | -10.44M | -7.85M | - | -7.05M | -2.17M |
| Minority Interests | - | - | - | - | - |
| Preferred Stock Dividends | 21.55M | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
